Levetiracetam-induced gingival hyperplasia
- PMID: 35848684
- PMCID: PMC9733520
- DOI: 10.4103/jpgm.jpgm_1059_21
Levetiracetam-induced gingival hyperplasia
Abstract
Levetiracetam is a new generation antiseizure medication which binds to synaptic vesicle protein SV2A and inhibits the release of neurotransmitters. Gingival hyperplasia is a common side effect of conventional antiseizure medications like phenytoin, but very rare with the newer ones. A 14-year-old boy was started on levetiracetam 250 mg twice daily after a generalized seizure. Five days later he presented with gingival swelling and painful oral aphthae, without lymphadenopathy or systemic symptoms. Blood investigations were normal. After one-month of stopping the drug, the lesions cleared. This case highlights the importance of maintaining good oral hygiene and periodic dental review in patients on antiseizure medications.
Keywords: Anticonvulsants; gingival hyperplasia; levetiracetam.
Conflict of interest statement
None
Figures
Similar articles
-
Nonsurgical Management of Phenytoin-induced Gingival Hyperplasia.J Contemp Dent Pract. 2015 Apr 1;16(4):319-21. doi: 10.5005/jp-journals-10024-1683. J Contemp Dent Pract. 2015. PMID: 26067737
-
Efficacy and safety profile of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children.Epilepsy Behav. 2020 Oct;111:107289. doi: 10.1016/j.yebeh.2020.107289. Epub 2020 Jul 20. Epilepsy Behav. 2020. PMID: 32702655
-
Levetiracetam for Seizure Prophylaxis in Neurocritical Care: A Systematic Review and Meta-analysis.Neurocrit Care. 2022 Feb;36(1):248-258. doi: 10.1007/s12028-021-01296-z. Epub 2021 Jul 20. Neurocrit Care. 2022. PMID: 34286461
-
Cost-utility analysis of levetiracetam and phenytoin for posttraumatic seizure prophylaxis.J Trauma. 2011 Aug;71(2):375-9. doi: 10.1097/TA.0b013e318224d307. J Trauma. 2011. PMID: 21825941
-
Phenytoin and carbamazepine cross reactivity: report of a case and review of literature.Postgrad Med J. 2003 Dec;79(938):703-4. Postgrad Med J. 2003. PMID: 14707249 Free PMC article. Review.
Cited by
-
Marked Gingival Overgrowth Protruding from the Oral Cavity Due to Sodium Valproate.Diagnostics (Basel). 2025 Jan 17;15(2):205. doi: 10.3390/diagnostics15020205. Diagnostics (Basel). 2025. PMID: 39857089 Free PMC article.
References
-
- Lyseng-Williamson KA. Spotlight on levetiracetam in epilepsy. CNS Drugs. 2011;25:901–5. - PubMed
-
- Mbizvo GK, Dixon P, Hutton JL, Marson AG. The adverse effects profile of levetiracetam in epilepsy: A more detailed look. Int J Neurosci. 2014;124:627–34. - PubMed
-
- Meraw SJ, Sheridan PJ. Medically induced gingival hyperplasia. Mayo Clin Proc. 1998;73:1196–9. - PubMed
-
- Informational paper: Drug-associated gingival enlargement. J Periodontol. 2004;75:1424–31. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources